These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. [Intravenous infusion of L-dopa: current prospective therapies]. Peppe A; De Angelis D; Tolli VS; Rizzo PA; Scoppetta C Riv Neurol; 1991; 61(5):197-200. PubMed ID: 1808680 [TBL] [Abstract][Full Text] [Related]
12. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease. Parkinson Study Group CALM Cohort Investigators Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655 [TBL] [Abstract][Full Text] [Related]
13. Long-acting carbidopa-levodopa in the management of moderate and advanced Parkinson's disease. Hutton JT; Morris JL Neurology; 1992 Jan; 42(1 Suppl 1):51-6; discussion 57-60. PubMed ID: 1549202 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological strategies for controlling motor fluctuations in Parkinson's disease. Ruggieri S; Carta A; Stocchi F; Antonini A; Bellantuono P; Monge A Funct Neurol; 1988; 3(4):471-9. PubMed ID: 3072281 [No Abstract] [Full Text] [Related]
15. Levodopa pharmacokinetic mechanisms and motor fluctuations in Parkinson's disease. Fabbrini G; Juncos J; Mouradian MM; Serrati C; Chase TN Ann Neurol; 1987 Apr; 21(4):370-6. PubMed ID: 3579222 [TBL] [Abstract][Full Text] [Related]
16. Dopaminergic responsiveness to apomorphine after chronic treatment with subcutaneous lisuride infusion in Parkinson's disease. Vaamonde J; Luquin MR; Obeso JA Mov Disord; 1990; 5(3):260-2. PubMed ID: 2388647 [TBL] [Abstract][Full Text] [Related]
17. [Sublingual administration of apomorphine in the treatment of motor fluctuations in Parkinson disease]. Durif F; Deffond D; Eschalier A; Tournilhac M Rev Neurol (Paris); 1992; 148(10):610-4. PubMed ID: 1295055 [TBL] [Abstract][Full Text] [Related]
18. Comparison between L-dopa and lisuride intravenous infusions: a clinical study. Ruggieri S; Stocchi F; Carta A; Bravi D; Bragoni M; Giorgi L; Agnoli A Mov Disord; 1988; 3(4):313-9. PubMed ID: 3211176 [TBL] [Abstract][Full Text] [Related]
19. Duodenal levodopa infusion improves quality of life in advanced Parkinson's disease. Antonini A; Mancini F; Canesi M; Zangaglia R; Isaias IU; Manfredi L; Pacchetti C; Zibetti M; Natuzzi F; Lopiano L; Nappi G; Pezzoli G Neurodegener Dis; 2008; 5(3-4):244-6. PubMed ID: 18322402 [TBL] [Abstract][Full Text] [Related]
20. [Aggravation of Parkinson's disease after inadequate use of levodopa in controlled-release preparations]. Mateo D; Dobato JL; Giménez-Roldán S Neurologia; 1995 Jan; 10(1):7-13. PubMed ID: 7893519 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]